Medivent International Limited
Medivent International Limited (Medivent) is a privately-held company, which is engaged in the design, manufacture and sale of non-invasive respiratory devices using a new and patented method of ventilation named as Biphasic Cuirass Ventilation (BCV). This ventilation method has been used on patients suffering with Neuromuscular, COPD, Cystic Fibrosis, ARDS patients, Acute Respiratory Failure and many more. Through utilizing BCV ventilation method, Medivent developed the RTX series of respirators. The company focuses on hospital and home markets, transport, emergency and military respiratory markets, the medical imaging market and the cardiac assist market. The company has a market presence in international markets through distribution agreements with leading national and international distributors in Europe, the Far East and the Middle East. Medivent is headquartered in London, United Kingdom.